v3.26.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Preferred stock
Common stock
Surplus
Treasury stock
Retained earnings
Accumulated other comprehensive loss
Beginning balance at Dec. 31, 2024 $ 6,344,297 $ 412,500 $ 66,560 $ 2,482,561 $ (6,153) $ 3,897,164 $ (508,335)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 600,820         600,820  
Other comprehensive income (loss), net of tax 193,527           193,527
Cash dividends declared on common stock (100,294)         (100,294)  
Dividends on Series D E and F preferred stock (27,277)         (27,277)  
Redemption of Series D and Series E preferred stock (412,500) (412,500)   14,046   (14,046)  
Stock-based compensation 30,646     30,646      
Issuance of Series F Preferred Stock 414,148 425,000   (10,852)      
Common stock issued for:              
Exercise of stock options 220   5 215      
Restricted stock awards (3,003)   435 (441) (2,997)    
Employee stock purchase plan 2,611   23 2,588      
Director compensation plan 2,562   19 2,543      
Ending balance at Sep. 30, 2025 7,045,757 425,000 67,042 2,521,306 (9,150) 4,356,367 (314,808)
Beginning balance at Jun. 30, 2025 7,225,696 837,500 67,025 2,495,637 (9,156) 4,200,923 (366,233)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 216,254         216,254  
Other comprehensive income (loss), net of tax 51,425           51,425
Cash dividends declared on common stock (33,469)         (33,469)  
Dividends on Series D E and F preferred stock (13,295)         (13,295)  
Redemption of Series D and Series E preferred stock (412,500) (412,500)   14,046   (14,046)  
Stock-based compensation 10,071     10,071      
Issuance of Series F Preferred Stock (64) 0   (64)      
Common stock issued for:              
Restricted stock awards 0   10 (16) 6    
Employee stock purchase plan 846   7 839      
Director compensation plan 793   0 793      
Ending balance at Sep. 30, 2025 7,045,757 425,000 67,042 2,521,306 (9,150) 4,356,367 (314,808)
Beginning balance at Dec. 31, 2025 7,258,715 425,000 67,062 2,534,024 (9,156) 4,537,539 (295,754)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 700,135         700,135  
Other comprehensive income (loss), net of tax (568,022)           (568,022)
Cash dividends declared on common stock (111,206)         (111,206)  
Dividends on Series D E and F preferred stock (25,101)         (25,101)  
Stock-based compensation 34,877     34,877      
Common stock issued for:              
Exercise of stock options 95   2 93      
Restricted stock awards (5,741)   484 (484) (5,741)    
Employee stock purchase plan 2,787   21 2,766      
Director compensation plan 3,007   30 2,977      
Ending balance at Sep. 30, 2026 7,289,546 425,000 67,599 2,574,253 (14,897) 5,101,367 (863,776)
Beginning balance at Jun. 30, 2026 7,525,116 425,000 67,581 2,560,427 (14,882) 4,907,788 (420,798)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 239,054         239,054  
Other comprehensive income (loss), net of tax (442,978)           (442,978)
Cash dividends declared on common stock (37,108)         (37,108)  
Dividends on Series D E and F preferred stock (8,367)         (8,367)  
Stock-based compensation 11,889     11,889      
Common stock issued for:              
Restricted stock awards (15)   10 (10) (15)    
Employee stock purchase plan 964   8 956      
Director compensation plan 991   0 991      
Ending balance at Sep. 30, 2026 $ 7,289,546 $ 425,000 $ 67,599 $ 2,574,253 $ (14,897) $ 5,101,367 $ (863,776)